ReviewAnnual review of medicine2024
Lessons Learned from Approval of Aducanumab for Alzheimer's Disease.
Judith L Heidebrink et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papertrialcites it
ReviewAnnual review of medicine2024
Judith L Heidebrink et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.